POT1 mutations cause telomere dysfunction in chronic lymphocytic leukemia

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Nature Genetics

• Publication date

  2013-03-17

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/ng.2584PMID 23502782
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hematological cancer in 2011: New therapeutic targets and treatment strategies

  2012cited by this paper
• DNA breaks and chromosome pulverization from errors in mitosis

  2012cited by this paper
• Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation

  2011cited by this paper
• Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia

  2011cited by this paper
• Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia

  2011cited by this paper
• Massive Genomic Rearrangement Acquired in a Single Catastrophic Event during Cancer Development

  2011cited by this paper
• Improving the assessment of the outcome of nonsynonymous SNVs with a consensus deleteriousness score, Condel.

  2011cited by this paper
• Telomeric and extra-telomeric roles for telomerase and the telomere-binding proteins

  2011cited by this paper
• SF3B1 and other novel cancer genes in chronic lymphocytic leukemia.

  2011cited by this paper
• International network of cancer genome projects

  2010cited by this paper
• Telomere dysfunction and fusion during the progression of chronic lymphocytic leukemia: evidence for a telomere crisis.

  2010cited by this paper
• Loss of Rap1 Induces Telomere Recombination in the Absence of NHEJ or a DNA Damage Signal

  2010cited by this paper
• COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer

  2010cited by this paper
• From pathogenesis to treatment of chronic lymphocytic leukaemia

  2010cited by this paper
• TPP1 is required for TERT recruitment, telomere elongation during nuclear reprogramming, and normal skin development in mice.

  2010cited by this paper
• Molecular basis of CLL.

  2010cited by this paper
• Jalview Version 2—a multiple sequence alignment editor and analysis workbench

  2009cited by this paper
• rtracklayer: an R package for interfacing with genome browsers

  2009cited by this paper
• POT1 Association with TRF2 Regulates Telomere Length

  2009cited by this paper
• Increased telomere fragility and fusions resulting from TRF1 deficiency lead to degenerative pathologies and increased cancer in mice.

  2009cited by this paper
• Distinct Functions of POT1 at Telomeres

  2008cited by this paper
• Short telomeres are associated with genetic complexity, high-risk genomic aberrations, and short survival in chronic lymphocytic leukemia.

  2008cited by this paper
• Clustal W and Clustal X version 2.0

  2007cited by this paper
• High-throughput telomere length quantification by FISH and its application to human population studies

  2007cited by this paper
• Pot1 deficiency initiates DNA damage checkpoint activation and aberrant homologous recombination at telomeres.

  2006cited by this paper
• Recent expansion of the telomeric complex in rodents: Two distinct POT1 proteins protect mouse telomeres.

  2006cited by this paper
• POT1 protects telomeres from a transient DNA damage response and determines how human chromosomes end

  2005cited by this paper
• Structure of human POT1 bound to telomeric single-stranded DNA provides a model for chromosome end-protection

  2004cited by this paper
• POT1 as a terminal transducer of TRF1 telomere length control

  2003cited by this paper
• Human Pot1 (Protection of Telomeres) Protein: Cytolocalization, Gene Structure, and Alternative Splicing

  2002cited by this paper
• Normal telomere length and chromosomal end capping in poly(ADP-ribose) polymerase–deficient mice and primary cells despite increased chromosomal instability

  2001cited by this paper
• Pot1, the Putative Telomere End-Binding Protein in Fission Yeast and Humans

  2001cited by this paper
• Telomere shortening and tumor formation by mouse cells lacking telomerase RNA.

  1997cited by this paper
• Chronic lymphocytic leukemia.

  1995cited by this paper

• Clinical, genetic, and familial features of POT1 tumor predisposition syndrome

  2026cites this paper
• Molecular Regulation of Telomeric Elongation and TERT Splicing in Planarians.

  2026cites this paper
• A unique presentation of multiple synchronous tumors in a patient with POT1 tumor predisposition syndrome

  2026cites this paper
• Single-stranded DNA-binding proteins at healthy and diseased telomeres.

  2026cites this paper
• Active telomere elongation by a subclass of cancer-associated POT1 mutations

  2025cites this paper
• In silico and in vitro mutational analysis to investigate the structure and pathogenicity of POT1 missense variants

  2025cites this paper
• Molecular Features Accompanying Richter’s Transformation in Patients with Chronic Lymphocytic Leukemia

  2025cites this paper
• EXABS-205-CLL: Data From NGS: What to Do With Additional Abnormalities Found at Diagnosis

  2025cites this paper
• Telomeres, telomerase, and cancer: mechanisms, biomarkers, and therapeutics

  2025cites this paper
• Mice carrying the homologous human shelterin POT1-L259S mutation linked to pulmonary fibrosis show a telomerase deficiency-like phenotype with telomere shortening with increasing mouse generations

  2025cites this paper
• UK clinical practice guidelines for the management of patients with constitutional POT1 pathogenic variants

  2025cites this paper
• Telomere Length Abnormality: Investigating Approaches and Correlations with Cancer, Bone Marrow Failure and Hematological Malignancies

  2025cites this paper
• Germline POT1 Variants in a Pan-Cancer Cohort.

  2025cites this paper
• Inherited Predispositions to Myeloid Neoplasms: Pathogenesis and Clinical Implications.

  2024cites this paper
• Recent Advances in the Molecular Biology of Chronic Lymphocytic Leukemia: How to Define Prognosis and Guide Treatment

  2024cites this paper
• Leveraging genomics, transcriptomics and epigenomics to understand chemoimmunotherapy resistance in chronic lymphocytic leukemia

  2024cites this paper
• Whole exome sequencing analyses reveal novel genes in telomere length and their biomedical implications

  2024cites this paper
• Germline POT1 Variants: A Critical Perspective on POT1 Tumor Predisposition Syndrome

  2024cites this paper
• Clonal hematopoiesis in cancer predisposition syndromes

  2024cites this paper
• Single nucleotide polymorphisms conferring susceptibility to leukemia and oral mucositis: a multi-center pilot study of patients prior to conditioning therapy for hematopoietic cell transplant

  2024influential citation
• CoPixie, a novel algorithm for single-particle track colocalization, enables efficient quantification of telomerase dynamics at telomeres

  2024cites this paper
• The molecular map of CLL and Richter's syndrome.

  2024cites this paper
• Telomeres and aging: on and off the planet!

  2024cites this paper
• Telomere maintenance and the DNA damage response: a paradoxical alliance

  2024cites this paper
• An Innovative Telomere-associated Prognosis Model in AML: Predicting Immune Infiltration and Treatment Responsiveness.

  2024cites this paper
• Combatting cellular immortality in cancers by targeting the shelterin protein complex

  2024cites this paper
• Cutaneous malignancies in chronic lymphocytic leukemia

  2024cites this paper
• Melanoma and Glioblastoma—Not a Serendipitous Association

  2023cites this paper
• Exploring Genetic Interactions with Telomere Protection Gene pot1 in Fission Yeast

  2023cites this paper
• POT1 mutations cause differential effects on telomere length leading to opposing disease phenotypes

  2023cites this paper
• Pot1b −/− tumors activate G-quadruplex-induced DNA damage to promote telomere hyper-elongation

  2023cites this paper
• TINF2 is a major susceptibility gene in Danish patients with multiple primary melanoma

  2023cites this paper
• Telomere Length and Clonal Hematopoiesis.

  2023cites this paper
• In-depth molecular analysis of lymphomas with lymphoplasmacytic differentiation may provide more precise diagnosis and rational treatment allocation

  2023cites this paper
• Familial Clonal Hematopoiesis in a Long Telomere Syndrome.

  2023cites this paper
• Genetic and Epigenetic Inheritance at Telomeres

  2022cites this paper
• POT1 mutations are frequent and associated with Ki-67 index in canine diffuse large B-cell lymphoma

  2022cites this paper
• Drug‐microenvironment perturbations reveal resistance mechanisms and prognostic subgroups in CLL

  2022cites this paper
• Identification of a Cancer-Predisposing Germline POT1 p.Ile49Metfs*7 Variant by Targeted Sequencing of a Splenic Marginal Zone Lymphoma

  2022cites this paper
• Telomerase‐based therapies in haematological malignancies

  2022cites this paper
• Advances in the understanding and treatment of Cutaneous T-cell Lymphoma

  2022cites this paper
• Genetics of human telomere biology disorders

  2022cites this paper
• A mouse model for Li-Fraumeni-Like Syndrome with cardiac angiosarcomas associated to POT1 mutations

  2022cites this paper
• Somatic reversion impacts myelodysplastic syndromes and acute myeloid leukemia evolution in the short telomere disorders

  2021influential citation
• Active and passive destabilization of G-quadruplex DNA by the telomere POT1-TPP1 complex.

  2021cites this paper
• Multi-platform profiling characterizes molecular subgroups and resistance networks in chronic lymphocytic leukemia

  2021cites this paper
• Pan-cancer analyses reveal regulation and clinical outcome association of the shelterin complex in cancer

  2021cites this paper
• Genetics of Chronic Lymphocytic Leukemia.

  2021cites this paper
• A Brief Overview and Update on Major Molecular Genomic Alterations in Solid, Bone and Soft Tissue Tumors, Hematopoietic As Well As Lymphoid Malignancies.

  2021cites this paper
• Somatic reversion impacts evolution of myelodysplastic syndromes and acute myeloid leukemia in the short telomere disorders.

  2021cites this paper
• Germline POT1 Deregulation Can Predispose to Myeloid Malignancies in Childhood

  2021cites this paper
• Prognostic and Predictive Implications of Cytogenetics and Genomics.

  2021cites this paper
• A Novel Screen for Expression Regulators of the Telomeric Protein TRF2 Identified Small Molecules That Impair TRF2 Dependent Immunosuppression and Tumor Growth

  2021cites this paper
• Germline POT1 Variants Can Predispose to Myeloid and Lymphoid Neoplasms

  2021cites this paper
• Clonal Evolution of High-Risk Chronic Lymphocytic Leukemia: A Contemporary Perspective

  2021cites this paper
• Non-canonical roles of canonical telomere binding proteins in cancers

  2021influential citation
• POT1 Regulates Proliferation and Confers Sexual Dimorphism in Glioma

  2021cites this paper
• Telomere Dysfunction in Chronic Lymphocytic Leukemia

  2021cites this paper
• Comprehensive characterisation of intronic mis-splicing mutations in human cancers

  2021cites this paper
• Telomere maintenance and genome stability

  2021cites this paper
• Cancer‐associated POT1 mutations lead to telomere elongation without induction of a DNA damage response

  2021influential citation
• The genomic landscape of canine diffuse large B-cell lymphoma identifies distinct subtypes with clinical and therapeutic implications

  2021cites this paper
• The genomic landscape of canine diffuse large B-cell lymphoma identi�es distinct subtypes with clinical and therapeutic implications

  2021cites this paper
• University of Birmingham Clonal evolution of high-risk chronic lymphocytic leukemia

  2021cites this paper
• Telomeres and Cancer

  2021cites this paper
• Somatic reversion impacts MDS/AML evolution in the short telomere syndromes

  2021influential citation
• Pathogenesis of chronic lymphocytic leukemia and the development of novel therapeutic strategies

  2020cites this paper
• Replication stress conferred by POT1 dysfunction promotes telomere relocalization to the nuclear pore

  2020cites this paper
• A Rare CD4−CD8+ Adult T-Cell Leukemia/Lymphoma with Unique Molecular Mutations: A Case Report with Literature Review

  2020cites this paper
• Mutational profiling of POT1 gene and its interaction with TPP1 in cancer- A computational approach

  2020cites this paper
• Role of POT1 in Human Cancer

  2020influential citation
• Role of Telomeres and Telomeric Proteins in Human Malignancies and Their Therapeutic Potential

  2020cites this paper
• MiR-185 targets POT1 to induce telomere dysfunction and cellular senescence

  2020cites this paper
• Impact of Gln94Glu mutation on the structure and function of protection of telomere 1, a cause of cutaneous familial melanoma

  2020cites this paper
• A rare missense variant in protection of telomeres 1 (POT1) predisposes to a range of haematological malignancies

  2020cites this paper
• A Germline Mutation in the POT1 Gene Is a Candidate for Familial Non-Medullary Thyroid Cancer

  2020cites this paper
• POT1-TPP1 telomere length regulation and disease

  2020influential citation
• Insights into Genetic Susceptibility to Melanoma by Gene Panel Testing: Potential Pathogenic Variants in ACD, ATM, BAP1, and POT1

  2020cites this paper
• The enigma of excessively long telomeres in cancer: lessons learned from rare human POT1 variants.

  2020cites this paper
• Tumor Suppressors in Chronic Lymphocytic Leukemia: From Lost Partners to Active Targets

  2020cites this paper
• Structural Features of Nucleoprotein CST/Shelterin Complex Involved in the Telomere Maintenance and Its Association with Disease Mutations

  2020influential citation
• Telomere-related Markers for Cancer

  2020cites this paper
• A Truncating Germline Mutation of TINF2 in Individuals with Thyroid Cancer or Melanoma Results in Longer Telomeres

  2020cites this paper
• POT1 mutation spectrum in tumour types commonly diagnosed among POT1-associated hereditary cancer syndrome families

  2020cites this paper
• Telomere relocalization to the nuclear pore complex in response to replication stress

  2020influential citation
• Genomic and Epigenomic Alterations in Chronic Lymphocytic Leukemia.

  2020influential citation
• A decade with whole exome sequencing in haematology

  2020influential citation
• Uncovering novel mutational signatures by de novo extraction with SigProfilerExtractor

  2020cites this paper
• A Single Center Retrospective Review of Patients from Central Italy Tested for Melanoma Predisposition Genes

  2020cites this paper
• TINF2 is a haploinsufficient tumor suppressor that limits telomere length

  2020cites this paper
• A novel germline mutation in the POT1 gene predisposes to familial non-medullary thyroid cancer

  2020cites this paper
• The prevalence and characterisation of TRAF3 and POT1 mutations in canine B-cell lymphoma.

  2020cites this paper
• Treatment of refractory acute myeloid leukaemia during pregnancy with venetoclax, high‐dose cytarabine and mitoxantrone

  2020cites this paper
• Multiple cancer pathways regulate telomere protection

  2019cites this paper
• Inhibiting TRF1 upstream signaling pathways to target telomeres in cancer cells

  2019cites this paper
• Association of gene mutations with time‐to‐first treatment in 384 treatment‐naive chronic lymphocytic leukaemia patients

  2019cites this paper
• Paracrine Interaction of Cancer Stem Cell Populations Is Regulated by the Senescence-Associated Secretory Phenotype (SASP)

  2019cites this paper
• Overview of non‐coding mutations in chronic lymphocytic leukemia

  2019cites this paper
• Chronic lymphocytic leukaemia: from genetics to treatment

  2019cites this paper
• Telomere dynamics in adult hematological malignancies.

  2019cites this paper